M & A / Tags / Pharmaceuticals

M & A Mon Mar 9, 2009 @ 3:02pm neoform

biz.yahoo.com -- By Chuck Mikolajczak NEW YORK (Reuters) - Stocks fell in choppy trade on Monday as gains in the energy and banking sectors were more than offset by a drop in pharmaceuticals after Merck's (NYSE:MRK - News) proposed $41 billion takeover of Schering-Plough.. Read More

M & A Tue Mar 3, 2009 @ 6:02pm neoform

biz.yahoo.com -- CAMBRIDGE, Mass. & LAVAL, Quebec--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX - News), which is developing the hepatitis C virus (HCV) protease inhibitor telaprevir, will add two polymerase inhibitors to its HCV drug development por.. Read More

M & A Thu Feb 26, 2009 @ 9:01am neoform

biz.yahoo.com -- - Acquisition of Four Clinical Stage Product Candidates Adds to Robust Pipeline - DALLAS, Feb. 26 /PRNewswire-FirstCall/ -- Access Pharmaceuticals, Inc. (OTCBB: ACCP - News) announced today that it has closed the acquisition of MacroChem Corporation thro.. Read More

M & A Tue Feb 17, 2009 @ 3:03pm neoform

biz.yahoo.com -- LAIYANG, China, Feb. 17 /PRNewswire-Asia-FirstCall/ -- Genesis Pharmaceuticals Enterprises, Inc. (OTC Bulletin Board: GNPH - News; "Genesis" or the "Company"), a U.S. pharmaceutical company with its principal operations in the People's Republic of China,.. Read More

M & A Wed Feb 4, 2009 @ 6:02pm neoform

biz.yahoo.com -- LEXINGTON, Mass., Feb. 4 /PRNewswire-FirstCall/ -- Indevus Pharmaceuticals, Inc. (Nasdaq: IDEV - News; the "Company") today announced its consolidated results of operations for the first quarter of fiscal 2009, ended December 31, 2008. The Company report.. Read More

M & A Thu Jan 29, 2009 @ 3:01pm neoform

biz.yahoo.com -- LAIYANG, China, Jan. 29 /PRNewswire-Asia-FirstCall/ -- Genesis Pharmaceuticals Enterprises, Inc. (OTC Bulletin Board: GNPH - News; "Genesis" or the "Company"), a U.S. pharmaceutical company with its principal operations in the People's Republic of China,.. Read More

M & A Thu Jan 22, 2009 @ 9:01am neoform

biz.yahoo.com -- SAN DIEGO, Jan. 22 /PRNewswire/ -- Axikin Pharmaceuticals, Inc., a startup company dedicated to developing and commercializing small molecule therapeutics for respiratory and inflammatory diseases, today announced a $3 million private placement of its Ser.. Read More

M & A Thu Dec 4, 2008 @ 9:02am neoform

biz.yahoo.com -- DUBLIN, December 4 /PRNewswire/ -- Azur Pharma Limited ("Azur") today announced that it has entered into a definitive agreement with BioSante Pharmaceuticals, Inc ("BioSante")(Nasdaq: BPAX - News) to acquire U.S. rights to Elestrin(TM). Elestrin is a fast.. Read More

M & A Tue Nov 25, 2008 @ 9:01am neoform

biz.yahoo.com -- CORONA, Calif., Nov. 25 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI - News), a leading specialty pharmaceutical company, today announced a definitive agreement to acquire a portfolio of generic pharmaceutical products that are being.. Read More

M & A Mon Nov 24, 2008 @ 9:02am neoform

biz.yahoo.com -- NEW YORK (AP) -- Alpharma has finally agreed to King Pharmaceuticals' $1.6 billion cash takeover offer, ending the drugmakers' months-long battle. King has agreed to pay $37 per share for Alpharma, representing a 54 percent premium to the Bridgewater, N... Read More

M & A Fri Nov 21, 2008 @ 3:03pm neoform

biz.yahoo.com -- MONTVALE, N.J., Nov. 21 /PRNewswire-FirstCall/ -- Barr Pharmaceuticals, Inc. (NYSE: BRL - News) today announced that its shareholders overwhelmingly approved the proposals submitted to them relating to the acquisition of Barr by Teva Pharmaceuticals Indus.. Read More

M & A Wed Nov 19, 2008 @ 6:01pm neoform

biz.yahoo.com -- NEW YORK--(BUSINESS WIRE)--Neuro-Hitech, Inc. (OTC BB: NHPI.OB - News), a New York-based pharmaceutical company focused on the development, marketing and distribution of branded and generic pharmaceutical products, today announced the modification of the.. Read More

M & A Thu Oct 16, 2008 @ 9:01am neoform

biz.yahoo.com -- ALISO VIEJO, Calif.--(BUSINESS WIRE)--Valeant Pharmaceuticals International (NYSE:VRX - News) today announced that it has completed its acquisition of Coria Laboratories, Ltd., a privately-held specialty pharmaceutical company focused on dermatology produ.. Read More

M & A Mon Oct 6, 2008 @ 12:02pm neoform

biz.yahoo.com -- NEW YORK (AP) -- Drug developer Alpharma said Monday it has agreed to share confidential financial information with King Pharmaceuticals, more than a week after rejecting a hostile takeover by King. Alpharma said in a regulatory filing that the agreement.. Read More

M & A Fri Sep 26, 2008 @ 3:02pm neoform

biz.yahoo.com -- BRISTOL, Tenn.--(BUSINESS WIRE)--King Pharmaceuticals, Inc. (NYSE: KG - News) today issued the following statement in response to an announcement by Alpharma Inc. (NYSE: ALO - News) regarding King’s offer to acquire Alpharma for $37.00 per share in cash.. Read More

M & A Wed Sep 24, 2008 @ 6:02pm neoform

biz.yahoo.com -- SAN DIEGO--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (NASDAQ: LGND - News) announced today that it has entered into a definitive merger agreement to acquire Pharmacopeia (NASDAQ: PCOP - News), in a deal valued up to $70 million. The transaction.. Read More

M & A Wed Sep 17, 2008 @ 12:01pm neoform

biz.yahoo.com -- FORT WORTH, Texas, Sept. 17 /PRNewswire/ -- H. Paul Dorman, Chairman and Chief Executive Officer of Fort Worth-based DFB Pharmaceuticals, Inc., today announced that DFB has signed a definitive agreement to sell its dermatology division Coria Laboratories,.. Read More

M & A Thu Sep 11, 2008 @ 3:02pm neoform

biz.yahoo.com -- BRIDGEWATER, N.J.--(BUSINESS WIRE)--The Board of Directors of Alpharma Inc. (NYSE: ALO - News), a global specialty pharmaceutical company, today urged shareholders to take no action with respect to the announcement by King Pharmaceuticals, Inc. (NYSE: KG.. Read More

M & A Tue Sep 2, 2008 @ 3:01pm neoform

biz.yahoo.com -- SCHAUMBURG, Ill. (AP) -- APP Pharmaceuticals Inc. said Tuesday U.S. regulators have cleared the way for its purchase by German dialysis-clinic operator Fresenius. In July, Hamburg-based Fresenius announced its plan to purchase APP for $3.7 billion in cas.. Read More

M & A Sat Aug 23, 2008 @ 9:07am neoform

biz.yahoo.com -- BRISTOL, Tenn.--(BUSINESS WIRE)--King Pharmaceuticals, Inc. (NYSE:KG - News) today held a conference call at 10:00 AM ET to discuss its proposal to acquire Alpharma Inc. (NYSE:ALO - News) for $33.00 per share in cash. Playback of the conference call and.. Read More